31st week of 2009 patent applcation highlights part 33 |
Patent application number | Title | Published |
20090191218 | DNA Vaccines And Methods For The Prevention Of Transplantation Rejection - Methods for preventing, delaying the onset of, or treating rejection of an allograft using a DNA vaccine, where the vaccine can comprise a polynucleotide encoding a pro-apoptotic protein, like BAX and/or a polynucleotide encoding an autoantigen or donor antigen, like secreted glutamic acid decarboxylase 55. Administering one of the DNA vaccines to a transplant recipient, as described herein, can induce a donor specific tolerogenic response. | 2009-07-30 |
20090191219 | METHODS FOR DIAGNOSING AND TREATING OBESITY BY MODULATING THE ACTIVITY OF AUTO-ANTIBODIES AGAINST THE MELANOCORTIN-4 RECEPTOR - Disclosed are biological markers for obesity and methods for diagnosing and treating obesity and related conditions by detecting and modulating the activity of auto-antibodies against the melanocortin-4 receptor or a portion of the melanocortin-4 receptor. Also disclosed are methods for discovering new therapeutics which modulate the activity of auto-antibodies against the melanocortin-4 receptor or a portion of the melanocortin-4 receptor, in particular which prevent the binding of auto-antibodies against the melanocortin-4 receptor or a portion of the melanocortin-4 receptor. | 2009-07-30 |
20090191220 | METHODS FOR THE DIAGNOSIS AND TREATMENT OF CRITICALLY ILL PATIENTS WITH ENDOTHELIN, ENDOTHELIN AGONISTS AND ADRENOMEDULLIN ANTAGONISTS - The ratio of concentrations of pro-adrenomedullin (pro-ADM)/pro-endothelin (pro-END) immunoreactivity in body fluids of critically ill patients is used as for the diagnosis, course control and prognosis, including an assessment of the mortality risk, of severe life threatening diseases. Further, a treatment of critically ill patients having high levels of pro-ADM but insufficient levels of pro-END immunoreactivities with a medicament comprising vasoconstrictive endothelin or its precursors, and/or endothelin agonists or adrenomedullin antagonists is provided. | 2009-07-30 |
20090191221 | ANTIBODIES RECOGNIZING A CARBOHYDRATE CONTAINING EPITOPE ON CD-43 AND CEA EXPRESSED ON CANCER CELLS AND METHODS USING SAME - The present invention provides antibodies (such as chimeric and humanized antibodies) specifically bind to an epitope on CD43 and CEA expressed on nonhematopoietic cancer cells. In addition, the present invention also provides use of the antibodies described herein for diagnostic and therapeutic purposes. | 2009-07-30 |
20090191222 | Metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression - This disclosure characterizes the function and the expression of the human protein encoded by tm9sf4. The protein is highly expressed in malignant tumor cells and therefore is a novel marker for malignancy. Moreover, the protein is involved in the phagocytotic character of tumor cells. This disclosure provides methods and tools to diagnose and follow up malignancy of tumors. Furthermore, means to inhibit phagocytotic character of tumor cells as well as means to treat cancer are provided. | 2009-07-30 |
20090191223 | Peptides that selectively home to heart vasculature and related conjugates and methods - The present invention provides a variety of isolated peptides and peptidomimetics, which can be useful, for example, in constructing the conjugates of the invention or, where the peptide itself has biological activity, in unconjugated form as a therapeutic for treating any of a variety of cardiovascular diseases as described below. Thus, the present invention provides an isolated peptide or peptidomimetic which has a length of less than 60 residues and includes the amino acid sequence CRPPR (SEQ ID NO: 1) or a peptidomimetic thereof. The invention further provides an isolated peptide or peptidomimetic which has a length of less than 60 residues and includes the amino acid sequence CARPAR (SEQ ID NO: 5) or a peptidomimetic thereof, or amino acid sequence CPKRPR (SEQ ID NO: 6) or a peptidomimetic thereof. | 2009-07-30 |
20090191224 | Nucleolin-Mediated Cancer Diagnostics and Therapy - The present invention provides for diagnostic kits for identifying cancer patients who are more susceptible to cancer therapies employing endostatin and other angiogenesis inhibitors, based upon the discovery that Nucleolin is a specific receptor for Endostatin. In particular, the diagnostic kits include antibody molecules against Nucleolin, DNA or RNA molecules that specifically bind to nucleic acid molecules encoding Nucleolin. The present invention also discloses methods of screening for angiogenesis inhibitors which specifically interact with Nucleolin, and act as angiogenesis inhibitors in an analogous manner as Endostatin. In addition, the present invention discloses methods of inhibiting the proliferation of endothelial cells or angiogenesis of tumor by administering an anti-nucleolin antibody linked to a cytotoxic agent such as tumor necrosis factor alpha to the endothelial cells. | 2009-07-30 |
20090191225 | Stably Tethered Structures of Defined Compositions with Multiple Functions or Binding Specificities - The present invention concerns methods and compositions for stably tethered structures of defined compositions with multiple functionalities and/or binding specificities. Particular embodiments concern stably tethered structures comprising a homodimer of a first monomer, comprising a dimerization and docking domain attached to a first precursor, and a second monomer comprising an anchoring domain attached to a second precursor. The first and second precursors may be virtually any molecule or structure, such as antibodies, antibody fragments, antibody analogs or mimetics, aptamers, binding peptides, fragments of binding proteins, known ligands for proteins or other molecules, enzymes, detectable labels or tags, therapeutic agents, toxins, pharmaceuticals, cytokines, interleukins, interferons, radioisotopes, proteins, peptides, peptide mimetics, polynucleotides, RNAi, oligosaccharides, natural or synthetic polymeric substances, nanoparticles, quantum dots, organic or inorganic compounds, etc. The disclosed methods and compositions provide a simple, easy to purify way to obtain any binary compound attached to any monomeric compound, or any trinary compound. | 2009-07-30 |
20090191226 | ADJUVANT FORMULATION COMPRISING A SUBMICRON OIL DROPLET EMULSION - An adjuvant composition, comprising a metabolizable oil and an emulsifying agent, wherein the oil and the detergent are present in the form of an oil-in-water emulsion having oil droplets substantially all of which are less than 1 micron in diameter. In preferred embodiments, the emulsifying agent is also an immunostimulating agent, such as a lipophilic muramyl peptide. Alternatively, an immunostimulating agent separate from the emulsifying agent can be used. | 2009-07-30 |
20090191227 | Compositions and Methods for Enhancing Immune Responses to Vaccines - The disclosure provides adjuvants, immunogenic compositions, and methods useful for vaccination and immune response. In particular, the disclosure provides a class of adjuvants comprising cationic lipid:co-lipid mixtures and methods for delivering formulated compositions. | 2009-07-30 |
20090191228 | Immunogenic compositions capable of activating T-cells - Provided is means and methods for producing and/or selecting immunogenic compositions capable of activating a T-cell and/or a T-cell response, comprising providing the composition with at least one cross-beta structure and testing at least one immunogenic property. | 2009-07-30 |
20090191229 | ADJUVANCY AND IMMUNE POTENTIATING PROPERTIES OF NATURAL PRODUCTS OF ONCHOCERCA VOLVULUS - The present disclosure relates to a method for inducing an antigen-specific immune response to an antigen in a mammal in need thereof, or potentiating an immune response, by administering to the mammal an effective amount of an isolated Ov-ASP, or at least one subunit of Ov-ASP. | 2009-07-30 |
20090191230 | CASCADE - The invention provides the use of an enzyme and a prodrug in the manufacture of a medicament for use in inducing an anti-tumour immune response in a human patient. | 2009-07-30 |
20090191231 | PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE - The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of Aβ and antibodies binding to the same. | 2009-07-30 |
20090191232 | Combination therapy for the treatment of tumors - The present invention relates to a combination therapy method for treating gastrin-dependent tumors. The method comprises the immunization of a patient with an anti-gastrin 17 immunogenic composition in combination with the administration of chemotherapeutic agents such as 5-fluorouracil and leucovorin. | 2009-07-30 |
20090191233 | INFLUENZA ANTIGEN DELIVERY VECTORS AND CONSTRUCTS - The present invention relates to fluorocarbon vectors for the delivery of influenza antigens to immunoresponsive target cells. It further relates to fluorocarbon vector-influenza antigen constructs and the use of such vectors associated with antigens as vaccines and immunotherapeutics in animals, including humans. | 2009-07-30 |
20090191234 | VACCINE - This invention relates to three newly-identified, distinct groups of antigenic peptides [LB1(f) peptides] from the same region of the P5-like fimbrin protein discovered using sequence data from the fimbrin protein of many | 2009-07-30 |
20090191235 | CONFORMATIONALLY STABILIZED HIV ENVELOPE IMMUNOGENS AND TRIGGERING HIV-1 ENVELOPE TO REVEAL CRYPTIC V3-LOOP EPITOPES - Stabilized forms of gp120 polypeptide, nucleic acids encoding these stabilized forms, vectors comprising these nucleic acids, and methods of using these polypeptides, nucleic acids, vectors and host cells are disclosed. Crystal structures and computer systems including atomic coordinates for stabilized forms of gp120, and gp120 with an extended V3 loop, and methods of using these structures and computer systems are also disclosed. | 2009-07-30 |
20090191236 | PIROPLASMID VACCINE - The invention relates to a Piroplasmid protein or an immunogenic fragment of said protein, and to a nucleic acid encoding said Piroplasmid protein or said immunogenic fragment. Furthermore, the invention relates to cDNA fragments, recombinant DNA molecules and live recombinant carriers comprising said nucleic acid. Also the invention relates to host cells comprising said cDNA fragments, recombinant DNA molecules and live recombinant carriers. Finally, the invention relates to vaccines comprising a Piroplasmid protein or an immunogenic fragment of said protein, to methods for the preparation of such vaccines, to the use of such proteins or fragments for vaccine purposes, and to diagnostic tests. | 2009-07-30 |
20090191237 | Methods and reagents for vaccination which generate A CD8 T cell immune response - New methods and reagents for vaccination are described which generate a CD8 T cell immune response against malarial and other antigens such as viral and tumour antigens. Novel vaccination regimes are described which employ a priming composition and a boosting composition, the boosting composition comprising a non-replicating or replication-impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition. | 2009-07-30 |
20090191238 | Method for producing yeast expressed HPV types 6 and 16 capsid proteins - Mosaic VLPs of viral capsid proteins from different virus types are described, as are methods of making the same. Specifically, a diploid yeast strain that coexpresses the L1 and L2 capsid proteins of both HPV-6 and HPV-16 as mosaic VLPs is described. The mosaic VLPs induced the production of conformational antibodies against both L1 proteins upon administration to mice. | 2009-07-30 |
20090191239 | RECOMBINANT INFECTIOUS LARYNGOTRACHEITIS VIRUS AND USES THEREOF - The present invention provides a recombinant, attenuated infectious laryngotracheitis virus comprising the infectious laryngotracheitis viral genome which contains a deletion in the glycoprotein gG gene. This attenuated virus is useful as a vaccine against infectious laryngotracheitis virus. | 2009-07-30 |
20090191240 | Flavivirus Vaccines - The invention provides flavivirus vaccines and methods of making and using these vaccines. | 2009-07-30 |
20090191241 | METHOD AND COMPOSITIONS FOR IMMUNIZATION WITH THE PSEUDOMONAS V ANTIGEN - A method of inhibiting, moderating or diagnosing | 2009-07-30 |
20090191242 | NOVEL HOMEOPATHIC STRAIN COMPRISING A NOSODE FROM A PROTOZOON OF THE GENUS TRYPANOSOMA - The present invention relates to a novel homeopathic strain characterized in that it comprises a nosode from a protozoon of the genus | 2009-07-30 |
20090191243 | High unsaponifiables and methods of using the same and its derivatives and uses thereof - Materials with high levels of unsaponifiable matter, such as extracts from plants, result in Hydrolysates with unique properties. It has been found that the application of a hydrolysis process to materials, particularly materials with a high level of unsaponifiables (e.g., at least 6% by total weight of the material) produces a product with properties significantly different from those products resulting from the conventional saponification of materials with less than 6% by weight of unsaponifiables. The resulting Hydrolysates from the practice of the present invention are substantive, resisting both physical and aqueous-based removal from skin and hair, exhibit a very unique surfactant property, and are not foaming agents with water. Addition of extra alkali metal hydroxides to these Hydrolysates according to the present invention may thus be used to neutralized acidic gelling agents and thereby providing a gel with enhanced the performance for cosmetics and pharmaceuticals. | 2009-07-30 |
20090191244 | MICROBUBBLES AND METHODS FOR OXYGEN DELIVERY - Compositions containing a carrier and microbubles encapsulating one or more gases, preferably oxygen, and methods for making and using the compositions are described herein. The microbubbles contain a lipid envelope formed of at least one base lipid and at least one emulsifying agent. The compositions may be administered to a patient to quickly deliver large amounts of oxygen to the patient's blood supply or directly to a tissue in need of oxygen. The compositions may be administered via injection or as a continuous infusion. The compositions contain a concentrated microbubble suspension, where the suspension contains at least 40 mL oxygen/dL suspension. The microbubbles are preferably less than 20 microns in diameter, more preferably less than 15 microns in diameter. The microbubbles described herein may be administered to a patient in an effective amount to increase in oxygen concentration in the patient's blood, and/or one or more tissues or organs. The microbubbles may be administered alone or in combination with other treatments as an adjuctive therapy. | 2009-07-30 |
20090191245 | REDUCED-IRRITANT DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE NAPHTHOIC ACID COMPOUND AND BENZOYL PEROXIDE AND TREATMENT OF KERATINIZATION DISORDERS THEREWITH - Topically applicable, reduced-irritant dermatological/cosmetic compositions useful for the prevention/treatment of a variety of keratinization disorders, for example acne vulgaris, contain at least one naphthoic acid compound and an amount of benzoyl peroxide encapsulated in a polymeric system of porous particles for increasing cutaneous penetration of the at least one naphthoic acid compound, are formulated into topically applicable, physiologically acceptable media therefor. | 2009-07-30 |
20090191246 | Method of producing scale-like composite particles - In a method of producing scale-like composite particles, a dispersion liquid is prepared to include scale-like inorganic particles coated with resin and spherical fine particles having an average particle diameter in a range from 0.1 to 3.0 μm. The scale-like inorganic particles coated with the resin and the spherical fine particles is dispersed in water, alcohol, or a mixture dispersant of the water and the alcohol. Then, the dispersion liquid is sprayed in a heated air stream for drying so that the spherical fine particles are adhered on the scale-like inorganic particles coated with resin by an electrostatic force generated by contact between the particles. | 2009-07-30 |
20090191247 | Anti-Viral Uses Of Carbon And Metal Nanomaterial Compositions - This invention generally relates to use of novel nanomaterials comprised of metals in anti-viral applications. Such nanomaterials, for example, can be produced using a high power, pulsed plasma process, which plasma process, optionally, can be performed on the metal with a precursor (i.e., a gaseous precursor, such as acetylene or methane) when forming the unagglomerated nanomaterials. In embodiments of the invention, the metal is nanosilver. Optionally, the nanomaterials may also comprise carbon, including in the form of carbyne. | 2009-07-30 |
20090191248 | HAND HEALTH AND HYGIENE SYSTEM FOR HAND HEALTH AND INFECTION CONTROL - The present disclosure is directed to a system and methods for maintaining or improving hand health and hygiene. More particularly, the system and methods prevent or overcome skin damage caused by frequent hand washing and use of hand sanitizers and/or cleansers. The hand care system comprises an article, such as an elastomeric glove, that has a moisturizing liquid liner composition on the skin-contacting surface of the article that delivers a skin health benefit to the skin, a non-irritating hand cleanser capable of moisturizing the skin, and a moisturizing hand sanitizer. | 2009-07-30 |
20090191249 | Sheet substrates impregnated with aromatic releasing compositions and a method of delivery of aromatic releasing compositions - An article of manufacture and a method directed to application of aromatic releasing compositions impregnated within substrates such as non-woven paper materials (e.g., wipes, paper towels) and dispensable cloth materials (e.g., gauze or a thin fabric of silk, linen, or cotton materials) for providing relief from cold, allergies, sinus and symptoms associated with respiratory disorders, the aromatic releasing compositions including the following: Menthol; Camphor; Eucalyptus oil; Cedarleaf Oil; Myristica Oil; Peppermint Oil; Lavender oil; Methyl Salicylate; Naproxen; Nutmeg Oil and Thymol; Beclometasone dipropionate; Benzethonium chloride with base solution consisting of Emollients, Emulsifiers and Moisturizer; Deionized Water; Vegetable Oil; Dicaprylyl Carbonate; Glyceryl Oleate; Polyglyceryl-2 Dipolyhydroxystearate; Cetearyl Isononanoate; Ceteareth-20; Cetearyl Alcohol; Glyceryl Stearate; Glycerin; Cetyl Palmitate; Ceteareth-12, Lauryl Glucose Carboxylate; Lauryl Glucoside; Sodium Citrate; Citric Acid; Benzethonium Chloride 0.05%; Ethylene diamine tetra acetic acid; Phenoxyethanol; Methylparaben; Propylparaben; 2-bromo-2-nitropropane-1,3-diol; and subcombinations thereof. In further embodiments, the compositions impregnated within substrate further include one or more topical actives, and are useful for providing relief from cold, allergies, sinus and symptoms associated with respiratory disorders, as well as repelling common virus and bacteria. | 2009-07-30 |
20090191250 | Antimicrobial Composite Material and Method for Fluid Treatment - Composite materials with broad spectrum antimicrobial properties and methods and devices for fluid treatment utilizing said materials are provided. The antimicrobial composite materials may include combinations of activated carbon and a biguanide hydrate. A particular composition includes a mixture of carbon particles and particles of chlorhexidine hydrate, which is useful in fixed particle bed water treatment devices and methods. | 2009-07-30 |
20090191251 | ANTIMICROBIAL MOLDED ARTICLE, LAMINATE, HEAT INSULATING MATERIAL AND SYNTHETIC LEATHER PRODUCT - An antimicrobial molding is prepared by mixing: an antimicrobial composition containing two organic antimicrobial agents selected solely from imidazole organic antimicrobial agent and an inorganic antimicrobial agent; and a curing material such as a thermoplastic resin, light-curing resin, resin cured by two-pack mixing to be formed as a sheet, film, multi-layer-structure and foamed article into a desired shape. Accordingly, a molding that contains the antimicrobial composition exhibiting significantly broad antimicrobial spectrum, negative skin irritation, high-level safety and extremely small influence on human body and environment, and efficiently achieves high antimicrobial effects can be easily obtained. | 2009-07-30 |
20090191252 | Pesticide compositions - This invention is related to the field of compositions useful in the control of pests that eat cellulose, such as, termites, where said composition is compacted and where said composition comprises alpha-cellulose, water, and a pesticide. | 2009-07-30 |
20090191253 | Use of K-252a and Kinase Inhibitors for the Prevention or Treatment of HMGB1-Associated Pathologies - The present invention relates to the use of K-252a, a physiologically active substance produced by microorganisms, and of its salts or synthetic and/or chemically modified derivatives for the prevention or treatment of HMGB1 associated pathologies. More particularly, the present invention relates to the use of K-252a for the prevention or treatment of restenosis. | 2009-07-30 |
20090191254 | INHIBITION OF BIOFILM FORMATION USING BACTERIOPHAGE - Disclosed herein are indwelling medical devices suitable for introduction into the body of a subject, wherein the indwelling medical devices comprise one or more surfaces on which a bacterial biofilm can form, and an effective amount of a bacteriophage composition carried by one or more of the surfaces, wherein the bacteriophage composition inhibits formation of the bacterial biofilm on the indwelling medical device. Also disclosed herein are methods of inhibiting the formation of bacterial biofilms on indwelling medical devices. | 2009-07-30 |
20090191255 | BMP-1 PROCOLLAGEN C-PROTEINASE FOR DIAGNOSIS AND TREATMENT OF BONE AND SOFT TISSUE DEFECTS AND DISORDERS - Uses of BMP-1 isoforms for diagnosing and treating defects and disorders of bone and soft tissues are described. Also described is a newly isolated variant of the BMP-1 isoform BMP-1-3. | 2009-07-30 |
20090191256 | HIGH WATER CONTENT OPHTHALMIC DEVICES - An ophthalmic device is disclosed that is a polymerization product of a monomeric mixture comprising (a) a major amount of a non-silicone-containing hydrophilic monomer; (b) a hydrophobic monomer; and (c) a crosslinking agent, wherein the ophthalmic device has an equilibrium water content of at least about 70 weight percent and further wherein the ophthalmic device has an evaporative dehydration barrier layer on the surface thereof. A method for the mitigation of evaporative corneal dehydration employing the high water content ophthalmic device is also disclosed. | 2009-07-30 |
20090191257 | PAIN RELIEF LOLLIPOP COMPOSITIONS AND METHODS - A pain relief lollipop comprises a candy matrix comprising (a) an opioid agonist, (b) an N-methyl-D-aspartate receptor antagonist different from the opioid agonist, (c) gabapentin, or a pharmaceutically acceptable salt thereof, and, optionally, a muscle relaxant, sedative, anxiolytic, and/or antidepressant. A patient can self-administer small amounts of the pain relief drug as needed by simply licking or sucking on the lollipop in response to his subjective experience of pain. | 2009-07-30 |
20090191258 | IODINE-CONTAINING COMPOSITIONS - Compositions provided according to embodiments of the present invention include an inorganic clay admixed with an iodine-containing substance. Suitable iodine-containing substances include I | 2009-07-30 |
20090191259 | Efficient liposomal encapsulation - The present invention concerns a method for preparing liposomes, said method comprising the following steps: (I) mixing at least one liposome-forming lipid, a water-miscible organic solvent and aqueous medium Y to form a gel or liquid containing gel particles without sonication; and thereafter (II) (a) mixing the gel or liquid containing gel particles with aqueous medium Z1 to directly form the liposomes; (b) (i) mixing the gel or liquid containing gel particles with aqueous medium Z1 to form a curd or curdy substance; and (ii) mixing the curd or curdy substance with aqueous medium Z2 to directly form the liposomes; or (c) (i) cooling the gel or liquid containing gel particles to form a waxy substance; and (ii) mixing the waxy substance with aqueous medium Z1 to directly form the liposomes; wherein aqueous media Y, Z1 and Z2 are the same or different. | 2009-07-30 |
20090191260 | AEROSOL AND USE THEREOF - The invention relates to an aerosol, in which a phase containing a solid substance is dispersed into a gaseous dispersant. The aim of the invention is to achieve a particularly effective anti-inflammatory action for the treatment of respiratory diseases. According to the invention, a depot is contained in the dispersed phase, said depot releasing silver ions when it comes into contact with water. | 2009-07-30 |
20090191261 | Antibody fragment-targeted immunoliposomes for systemic gene delivery - Nucleic acid-immunoliposome compositions useful as therapeutic agents are disclosed. These compositions preferably comprise (i) cationic liposomes, (ii) a single chain antibody fragment which binds to a transferrin receptor, and (iii) a nucleic acid encoding a wild type p53. These compositions target cells which express transferrin receptors, e.g., cancer cells. These compositions can be used therapeutically to treat persons or animals who have cancer, e.g., head and neck cancer, breast cancer or prostate cancer. | 2009-07-30 |
20090191262 | USE OF COMPOUNDS OF FORMULA A-R-XO PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF FOR PRODUCING A PHARMACEUTICALLY PREPARATIONS - The invention relates to a compound of formula A-R-X or pharmaceutically acceptable salts thereof which can be used for producing a pharmaceutical preparation suitable for preventing or treating cancerous diseases, pathological consequences of alcohol abuse, viral hepatitis, steatohepatitis, acute and chronic pancreatitis, toxic renal diseases, hepatic insulin resistance in diabetes mellitus, hepatic damage in Wilson's disease and sideroses and/or ischaemic reperfusion damage, as an antidote against environmental toxins and medicament intoxication in order to extend the resistance time of medicaments in organisms, or for combating toxic side effects in the administration of chemotherapeutics. In the formula R is an aliphatic or aromatic C | 2009-07-30 |
20090191263 | COMPOSITIONS AND METHODS FOR SIRNA INHIBITION OF HIF-1 ALPHA - RNA interference using small interfering RNAs which target HIF-1 alpha mRNA inhibit expression of the HIF-1 alpha gene. As HIF-1 alpha is a transcriptional regulator of VEGF, expression of VEGF is also inhibited. Control of VEGF production through siRNA-mediated down-regulation of HIF-1 alpha can be used to inhibit angiogenesis, in particularly in diseases such as diabetic retinopathy, age related macular degeneration and many types of cancer. | 2009-07-30 |
20090191264 | EPOTHILONE COMPOSITIONS - This invention provides liposomal compositions comprising an epothilone. | 2009-07-30 |
20090191265 | Capsule Formulation of Pirfenidone and Pharmaceutically Acceptable Excipients - A capsule formulation of pirfenidone is provided that includes pharmaceutically acceptable excipients. In one embodiment, this capsule formulation is capable of sustaining desirable pharmacokinetic responses in a patient. Further provided are methods of treating fibrotic conditions and other cytokine-mediated disorders by administering pirfenidone capsules of such formulation to a patient in need. | 2009-07-30 |
20090191266 | Pregelatinized Starch In A Controlled Release Formulation - The present invention concerns the use of pregelatinized starch to prevent dose-dumping from a hydrophilic controlled release formulation. It also concerns a hydrophilic controlled release formulation, more in particular a hydrophilic controlled release matrix formulation, and solid dosage forms prepared therefrom, preferably for once daily oral administration. The hydrophilic controlled release formulation comprises pregelatinized starch, one or more active ingredients, one or more viscous hydrophilic polymers and optionally pharmaceutically acceptable formulating agents. Preferred hydrophilic polymers include hydroxypropyl cellulose and hydroxypropyl methylcellulose. | 2009-07-30 |
20090191267 | Oral Compositions Containing a Salivation Inducing Agent - Oral dosage forms, and particles used therein, containing salivation inducing agents are disclosed. The salivation agents may be in the core of the dosage form and/or in coatings applied thereto, or alternatively may be within particles and/or the matrix of such dosage forms, in coatings applied to such particles, or on the surface of such coated particles. The particles may be produced into a tablet form, such as a chewable tablet form, that provides for the immediate release of the active ingredient. Other oral dosage forms include thin film strips, gummi, foam tabs, and lozenges. | 2009-07-30 |
20090191268 | ALLERGY VACCINES - The invention provides methods and materials related to vaccines against self polypeptides. For example, the invention provides compositions containing chimeric IgE polypeptides and adjuvants. | 2009-07-30 |
20090191269 | USE OF GELATIN AND A CROSS-LINKING AGENT FOR PRODUCING A CROSS-LINKING THERAPEUTIC COMPOSITION - A therapeutic composition comprising gelatin and a cross-linking agent, for use in biological regenerative methods, which composition can be administered to a target area of the body while ensuring that the suspended cells and/or the growth factors remain in the target area of the body and at the same time eliminating the need for the patient to maintain the treated body area immobilized for unreasonable periods, is disclosed. A method is also disclosed, wherein (i) the gelatin and the cross-linking agent are mixed with each other to form the cross-linking therapeutic composition which is then administered to the target area; or (ii) the gelatin and the cross-linking agent are made available in separate form and are administered, simultaneously or one after the other, to the target area while forming the cross-linking therapeutic composition. | 2009-07-30 |
20090191270 | STRUCTURE AND METHOD FOR RELEASING SUBSTANCE THEREFROM - A structure comprises at least a porous body holding a substance releasably, comprising a capping member for keeping the substance inside the pore and/or on at least a part of the entire surface of the porous body, and a connecting member for connecting the porous body and the capping member separably, the connecting member comprising a biopolymer compound. | 2009-07-30 |
20090191271 | Topical Formulations - Saturated, monophasic solutions of drug in a solvent and propellant mixture, together with a film-forming agent, exhibit transdermal diffusion fluxes greater than those predicted by Fick's law when applied topically. | 2009-07-30 |
20090191272 | Use of vegetable fine grain sized fibres for preparing a nutritional composition for reducing mycotoxin bioavailability - The invention relates to using substantially insoluble vegetable fibres embodied in the form of microparticles at least 90% in weight of which has a size less than 700 μm as ingredients for preparing a nutritional composition for reducing a mycotoxin bioavailability in a human being or an animal during ingestion of a food contaminated by said mycotoxins. | 2009-07-30 |
20090191273 | Metal Oxide Dispersion - A dispersion contains particles of metal oxide having a median volume particle diameter in the range from 24 to 42 nm which are dispersed in a medium which includes a mixture of at least one polar material having an interfacial tension of less than 30 mNm | 2009-07-30 |
20090191274 | Pharmaceutical composition of amlodipine maleate having enhanced stability - The present invention relates to a coated particle of amlodipine maleate and a pharmaceutical composition for cardiovascular disease (CVD) comprising the coated particle of amlodipine maleate. The pharmaceutical composition of the present invention has stable bioavailability due to sufficient dissolution rate and prevents decomposition reaction of amlodipine to thereby being formulated with formulation-stability equal to or higher than amlodipine besylate under long storage. | 2009-07-30 |
20090191275 | VISCOUS BUDESONIDE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT - Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention. | 2009-07-30 |
20090191276 | COLLOIDOSOMES HAVING TUNABLE PROPERTIES AND METHODS FOR MAKING COLLOIDOSOMES HAVING TUNABLE PROPERTIES - Colloidosomes having tunable properties, methods for making the same, and applications thereof are described. Colloidosomes described herein are responsive to certain external stimulus to alter one or more properties of the colloidosome. Methods for making colloidosomes include forming a shell of colloidal particles on a core material where the colloidal particles and the core material have attractive interactions. | 2009-07-30 |
20090191277 | PROTEIN NANOPARTICLES - It is an object of the present invention to provide a highly safe composition comprising minoxidil and having high transparency due to the small particle size and high permeability into scalp and hair follicles. The present invention provides a protein nanoparticle which comprises minoxidil. | 2009-07-30 |
20090191278 | HOMEOPATHY-BASED FORMULATION - A formulation comprising a potentized mixture of triturated Lichen planus tissue with histamine in the ratio of about 1:2 to about 2:1 in a vehicle, where the ratio of the mixture to the vehicle, can be varied from 1:99 to 50:50. | 2009-07-30 |
20090191279 | FLUORIDE VARNISH COMPOSITIONS INCLUDING AN ORGANO PHOSPHORIC ACID ADHESION PROMOTING AGENT - Fluoride varnish compositions for temporary application and adhesion to a person's teeth. The composition includes a carrier comprising a resin and an adhesion promoting agent comprising an alkyl phosphoric acid. A fluoride ion source (e.g., a fluoride salt such as sodium fluoride) is dispersed within the carrier so as to provide biologically available fluoride ions to the tooth tissue being treated. The composition adheres only temporarily to tooth tissue (e.g., for a period of at least about 4 minutes, but not more than about 1 year), after which the composition spontaneously wears away as a natural result of the action of the tongue, saliva and/or other factors. | 2009-07-30 |
20090191280 | HARD TISSUE REPAIRING MATERIAL - A hard tissue repairing material includes zirconia as a base material. A surface of the base material has a hydrophilic group. The hydrophilic group is bonded to zirconium atom in the base material. The base material may contain at least an ionic component that is selected from a group consisting of calcium ion, sodium ion, potassium ion, and phosphate ions within the surface. A hard tissue repairing material may include zirconia as a base material and a layer of a main component of an apatite. The layer of the apatite may be formed on a hydrophilic group bonded to zirconium atom in the base material. | 2009-07-30 |
20090191281 | PHARMACEUTICAL COMPOSITION, PROCESS FOR MANUFACTURING THE SAME AND ITS MEDICAL DEVICE FOR THE TREATMENT OF CUTANEOUS LESIONS - Use, method of manufacturing a pharmaceutical composition, pharmaceutical composition for the treatment of skin ailments comprising a therapeutic quantity in aqueous solution of nitric acid of 5 to 15 mmol/ml of pharmaceutical composition, and also comprising a zinc salt at a concentration of 0.01 to 0.015 mg of Zn | 2009-07-30 |
20090191282 | CONTROLLED RELEASE COMPOSITION CONTAINING A STRONTIUM SALT - A controlled release pharmaceutical composition comprising a strontium salt. The invention also relates to the use of a strontium salt for treating a male suffering from diseases and conditions affecting metabolism and/or structural integrity of cartilage and/or bone. The invention also relates to the use of a strontium-containing compound for preventing a cartilage and/or bone condition in a subject, and for the treatment and/or prophylaxis of secondary osteoporosis. | 2009-07-30 |
20090191283 | TREATMENT OF HEADACHES, NECK PAIN, JOINT PAIN AND INFLAMMATORY-TYPE PAIN - The formulation provides a method of treating headaches, neck, joint and inflammatory-type pain in a mammalian subject by administering to the subject a therapeutically effective amount of a nitrate-containing compound and a therapeutically effective amount of a selenium-containing compound. The formulation also provides kits and systems for practicing the subject methods. | 2009-07-30 |
20090191284 | USE OF NITROANILINE DERIVATIVES FOR THE PRODUCTION OF NITRIC OXIDE - The present disclosure relates to the use of a nitroaniline derivative of Formula (I) for the production of nitric oxide and for the preparation of a medicament for the treatment of a disease wherein the administration of nitric oxide is beneficial. The present disclosure furthermore relates to a method for the production of NO irradiating a nitroaniline derivative of Formula (I), a kit comprising a nitroaniline derivative of Formula (I) and a carrier and to a system comprising a source of radiations and a container associated to a nitroaniline derivative of Formula (I). In Formula (I), R and R | 2009-07-30 |
20090191285 | MOISTURIZING LIQUID LINER FOR BARRIER LAYER - A moisturizing liquid liner composition comprising a hydrophobic moiety and an emulsifier is described. Further, a substrate comprising a barrier layer and a moisturizing liquid liner composition comprising a hydrophobic moiety and an emulsifier is described. The substrate may be incorporated into an article. | 2009-07-30 |
20090191286 | Binding and Rinse-Off of Quaternary Ammonium Compounds for Cosmetic and Personal Care Applications - The disclosed composition and method includes the use of non-polar unsaponifiable material and polar hydrophilic salts in conjunction with quaternary ammonium compounds to provide hair treatment preparations for cosmetic and personal care applications. Disclosed features and specifications may be variously controlled, adapted or otherwise optionally modified to improve substantivity and/or rinse-off characteristics. Exemplary embodiments of the present invention generally provide hair conditioners, shampoos, straighteners, permanent waves, color-fast dyes, non-color-fast dyes, and repair treatments with jojoba hydrolysates in combination with Quaternium 80 for increased substantivity and superior wash/rinse-off benefits. | 2009-07-30 |
20090191287 | Mitigation of Inflammation-Related Injuries - The present invention comprises formulae and methods that mitigate post-trauma inflammation, thus reducing overall damage to a patient. The formulae includes a uric acid agent, preferably a uric acid inhibitor, along with at least one other compound that is an inflammatory response suppressor. One preferred inflammatory response suppressor is a compound that reduces the omega 6/omega 3 EFA ratio in the body and preferably includes a source of omega 3 EFAs. The formulae are designed to minimize the formation of uric acid, which stimulates inflammatory response, and also minimize the production of ROS, an abundance of which is required for several inflammatory precursors or processes. A method of the present invention preferably includes prophylactic treatment of patients who are at risk for trauma, particularly traumatic brain injury, and includes daily administration of the selected formulation during the period of time in which risk is present. | 2009-07-30 |
20090191288 | Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases - An improved method (process) and medicinal composition is provided to treat herpes, pseudomonas, hepatitis, staph (staphylococci) and other infectious diseases The inexpensive medicinal composition can be self-administered and maintained for a prescribed time. The attractive medicinal composition can comprise a quaternary ammonium salt surfactant, a skin protectant and an alcohol. The quaternary ammonium salt surfactant can comprise benzalkonium halide, preferably benzalkonium chloride. The skin protectant can comprise Allantoin. The alcohol can serve as a pain reliever and can comprise benzyl alcohol. The medicinal composition can also include other compounds, additives, herbal extracts and/or carriers. | 2009-07-30 |
20090191289 | ANTIMICROBIAL COMPOSITIONS - The present invention provides an antimicrobial composition comprising an antimicrobial effective amount (such as a preservative, bactericidal, and/or fungicidal effective amount) of a mixture comprising at least two of:
| 2009-07-30 |
20090191290 | DIETARY SUPPLEMENTS CONTAINING EXTRACTS OF CINNAMON AND METHODS OF USING SAME TO ENHANCE CREATINE TRANSPORT - Materials derived from cinnamon can be administered orally to humans or animals for the purpose of controlling blood glucose as well improving glucose tolerance. Controlling glucose metabolism is essential for those with impaired glucose metabolism as is the case for those with Type II diabetes where insulin function is not properly functioning. Such administration can also be used for the purpose of enhancing nutrient transport for purposes of athletic performance and controlling bodyweight and body fat levels. Similarly related, such administration can also be used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material can be administered as extracts of cinnamon and can be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks. | 2009-07-30 |
20090191291 | Cosmetology product for skin and hair - The invention provides compositions for external application to the skin and/or hair. The composition may be used to treat burns, particularly minor burns, sunburns, eczema, psoriasis, dry or bleeding cuticles, dry or rough skin, athletes foot, razor rash or razor burn, cold sores, dry or chapped lips, dry or frayed hair, and/or combinations thereof. | 2009-07-30 |
20090191292 | High essential oil and eugenol yielding cultivar of ocimum sanctum 'CIM-AYU' - The present invention relates to the development of a novel high herb yielding essential oil herb variety of Krishna Tulsi (botanically known as | 2009-07-30 |
20090191293 | Composition for enhancing immunity and reducing inflammation related to infections - A composition and method for enhancing immunity and reducing or inhibiting inflammation related innate immune system activation while affording the body of a user protection against known detrimental byproducts of immune-response is provided. The composition comprises at least a therapeutically effective amount of vitamin C and extract of | 2009-07-30 |
20090191294 | Grape cane product, and method of making - An extract of the grape plant obtained from grape plant cane is a powerful anti-oxidant, and offers a unique combination of beneficial organic chemicals, including trans-resveratrol, trans-viniferin, and oligostiibines. The grape plant cane product is produced essentially exclusively from grape plant cane, which is often discarded by vintners. Methods of making this product include solvent extraction from the grape plant cane, followed by vacuum drying without overheating the product. The grape plant cane extract may be used as an anti-fungal, antibiotic, antiseptic, preservative, as a topical application to improve moisture retention of human skin, and to extend the shipping and shelf life of produce, among other uses. A method for using the grape plant cane extract as a food supplement involves daily human ingestion of desired amounts of a food-grade grape plant cane product. | 2009-07-30 |
20090191295 | Molding machine and temperature control method thereof - A molding machine ( | 2009-07-30 |
20090191296 | Apparatuses and processes for packaging products - An apparatus comprises an operating device and a die suitable for interacting to form containers from a sheet material, a cutting device for separating said containers from said sheet material, said cutting means being so shaped as to be removably connectable to said operating device. | 2009-07-30 |
20090191297 | TABLET PRESS - A tablet press with a rotor, which is rotatably mounted in a stand of the tablet press and which has an upper punch accommodation for the upper punches and a lower punch accommodation for the lower punches of the tablet press, as well as a die plate with a series of die bores which are aligned with the upper and the lower punches, wherein the die plate consists of at least two ring segments which can be attached on the rotor by means of a fastening device, wherein clamping elements are arranged in axis parallel passages of the rotor spaced apart in the perimeter distance, which act against the ring segments from the bottom side and clamp against an abutment surface of the rotor, characterised in that at least one drive device for the clamping elements is arranged in the stand of the tablet press, with a coupling element adjustable in the height, which can be selectively set into engagement with the lower end of the clamping element. | 2009-07-30 |
20090191298 | METHOD OF MANUFACTURING REINFORCING CLOTH OF SHEET PAD AND APPARATUS THEREFOR - A method of manufacturing a reinforcing cloth of a sheet pad includes: fixing a sheet on a mold having an outer shape substantially identical to a shape of the reinforcing cloth and provided with a plurality of air holes interconnecting an internal space with an outer surface; forming a closed space between the mold and a cover member by covering the sheet fixed on the mold with the cover member; heating the sheet; shaping the heated sheet into a shape following the outer shape of the mold by exhausting air from the closed space through the air holes; and demolding the sheet from the mold after removing the cover member. | 2009-07-30 |
20090191299 | MOLDING APPARATUS - A molding apparatus includes a first mold half, first mold core received in the first mold half, a second mold half including a receiving cavity defined therein, a second mold core, a spacer and a bolt. The second mold half is positioned opposite to the first mold half. A first through hole is defined in the second mold half and in communication with the receiving cavity. The second mold core is received in the receiving cavity. The second mold core defines a threaded hole in a peripheral surface thereof aligned with the first through hole. The spacer is configured for being positioned between the second mold core and the second mold half. The spacer defines a second through hole therein. The bolt passes through the first through hole and is screwed in the threaded hole for securing the second mold core to the second mold half. | 2009-07-30 |
20090191300 | Flexible Plate Slot for a Hot Runner Injection Molding System - A flexible plate system for a hot runner assembly includes a backing plate; a manifold plate detachably connected to the backing plate; a manifold positioned between the backing plate and the manifold plate and having at least one nozzle associated therewith; and wherein the manifold plate has at least one plate slot that allows the nozzle to extend through the manifold plate and having at least a first lateral dimension substantially larger than the outside diameter of the nozzle. The manifold plate and the backing plate may be configured to have at least one manifold plate cavity and at least one backing plate cavity to accept at least one nozzle insert and at least one piston cylinder insert respectively, the nozzle insert having a nozzle bore or a plurality of insert slots therethrough for installation of the nozzle, and the piston cylinder insert having a cylinder bore for a piston cylinder. | 2009-07-30 |
20090191301 | Flexible Plate Slot for a Hot Runner Injection Molding System - A flexible plate system for a hot runner assembly includes a backing plate; a manifold plate detachably connected to the backing plate; a manifold positioned between the backing plate and the manifold plate and having at least one nozzle associated therewith; and wherein the manifold plate has at least one plate slot that allows the nozzle to extend through the manifold plate and having at least a first lateral dimension substantially larger than the outside diameter of the nozzle. | 2009-07-30 |
20090191302 | Reconfigurable Hot Runner - A hot runner system having a melt distribution system that is reusable and reconfigurable to vary drop or nozzle locations to meet various design requirements. The melt distribution system includes a melt distributor in fluid communication with a melt source, at least one melt conduit in fluid communication with the melt distributor, and at least one nozzle in fluid communication with the at least one melt conduit. The hot runner system also includes a backing plate; a manifold plate detachably connected to the backing plate; a melt distribution system positioned between the backing plate and the manifold plate and having at least one nozzle associated therewith. The hot runner system may be configured and reconfigured to accommodate various drop or nozzle locations. | 2009-07-30 |
20090191303 | Mold Assembly for Manufacturing Blades of a Fan and the Method for Manufacturing the Same - A mold assembly for manufacturing the blades of a fan and the method for manufacturing the same are provided. The mold assembly comprises a lower blade mold, a modulating mold block and a positioning device, wherein the positioning device sustains between the lower blade mold and the modulating mold block to prevent the relative movement thereof. The modulating mold block is received in a central receiving space of the lower blade mold, and comprises at least one recess and at least one modulating element, wherein the at least one modulating element is correspondingly received in the recess to modulate the blades of the fan into optimal kinetic equilibrium after being formed. | 2009-07-30 |
20090191304 | MINERAL LICK - A process of attracting land animals and/or supplementing the diet of land animals with mineral nutrients involves selecting a location for attracting and/or supplementing the diet of the land animals and disposing at the selected location a compressed cohesive mass of mineral components that when consumed promotes health and/or growth, wherein the compressed cohesive mass of mineral components has a size, shape and mass that facilitates portability, ease of delivery to a selected location and avoidance of communal consumption that could promote the transmission of disease. | 2009-07-30 |
20090191305 | Method of Increasing Activity - The present invention relates to a method of increasing the physical activity of a cat, the method comprising feeding said cat a dry cat food with added water. The dry food may be in the form of kibbles. | 2009-07-30 |
20090191306 | NUTRITIONAL COMPOSITION CONTAINING DHA, RUMENIC ACID, AND GANGLIOSIDES - In accordance with the present invention, a nutritional composition, a method for enhancing the immune system development in an infant, and a method for reducing allergic inflammatory responses in an infant are provided. The nutritional composition comprises a protein source, a fat source, a carbohydrate source, rumenic acid, DHA, and at least one ganglioside. Both methods comprise administering to the infant a combination of rumenic acid, DHA, and at least one ganglioside. | 2009-07-30 |
20090191307 | COMPOSITIONS FOR FEEDING ANIMALS - Feed compositions comprising modified starches and an animal feed ingredient are disclosed, as well as methods of feeding such compositions to animals. | 2009-07-30 |
20090191308 | Method of preparing emulsified cereal bran derivatives - The present invention provides a method for preparing emulsified bran derivatives and emulsified bran fractions which can be used in the preparation of nutritionally-enriched food and beverage products. | 2009-07-30 |
20090191309 | Process for recovering aroma from tea - Disclosed is a process for recovering volatile aroma compounds from a tea material. The process comprises the steps of: generating aroma-laden vapours at a pressure of from 0.5 to 1.4 bar absolute from the tea material contacted with water or water vapours, and then condensing the aroma-laden vapours to recover aroma condensate. The process is controlled such that the mass of aroma condensate generated per unit dry mass of tea material is greater than 2 and the aroma-laden vapours comprise no more than 1% by weight entrained liquid. | 2009-07-30 |
20090191310 | Method for Reducing Acrylamide in Foods, Foods Having Reduced Levels of Acrylamide and Article of Commerce - A method for the reduction of acrylamide in food products, food products having reduced levels of acrylamide, and an article of commerce. In one aspect, the method comprises reducing the level of asparagine in a food material before final heating (e.g., cooking). In another aspect, the method comprises adding to a food material an enzyme capable of hydrolyzing the amide group of free asparagine. In yet another aspect, an article of commerce communicates to the consumer that a food product has reduced or low levels of acrylamide or asparagine. | 2009-07-30 |
20090191311 | BEVERAGE PACKED IN FOAM CONTAINER - Provided is a packaged effervescent beverage having a high concentration of catechins, having both reduced bitterness and adequate sweetness, and not undergoing a substantial reduction in the catechin content even after long storage albeit containing a sweetener. | 2009-07-30 |
20090191312 | Novel stabilized carotenoid compositions - Compositions comprising a carotenoid and/or fat-soluble vitamin in a matrix of a protein which is cross-linked with a reducing substance, a solid vegetable fat and, optionally, auxiliary agents provide increased stability of the carotene and/or vitamin when incorporated into food, particularly a vegetable fat. | 2009-07-30 |
20090191313 | Method for Making a Coated Food Product Having a Heat Susceptible Coating - A method for making a coated food product having a heat susceptible coating is disclosed. In one aspect, the invention is directed towards a nut having a proteinaceous or fruit-based coating with no visible scorching in the outer, visible coating layer. In one aspect, the food center is par-coated with or without a heat susceptible coating, pre-roasted, finished coated with or without a heat susceptible coating, and cooked. In another aspect, the food center is first coated with a heat susceptible coating, then coated with a non-heat susceptible coating and cooked. In yet another aspect, the food center is coated with a heat susceptible coating and then cooked in a two-stage process whereby the first stage is at a hotter temperature than the second stage. | 2009-07-30 |
20090191314 | SYSTEM FOR GENERATING UNIQUELY FLAVORED TREATS - A method for encouraging the development of new flavors, wherein the method includes the steps of providing a plurality of sets of comestible pieces available for combination experimentation, providing a plurality of predetermined flavor combination suggestions, and encouraging experimental combination of comestibles from different sets. Preferably, each set is characterized by a unique flavor and the flavor of each piece is provided by a predetermined amount of flavoring contained therein. Also preferably, the predetermined amount of flavoring contained in each piece is standardized relative to flavor intensity. Optionally, rewards are given for the development or identification of successful flavor combinations. | 2009-07-30 |
20090191315 | Uncooked dry or semi-dry sausage product having a casing made of a textile sheet - The invention relates to uncooked dry or semi-dry sausage products in tubular casings that are based on an optionally-coated textile material. The tubular casing has a longitudinal seam with a sealing strip. On the sealing strip is located a discontinuous layer of a sealing polymer. The sealing strip is bonded to the casing essentially at sealing points defined by the discontinuous layer. The invention further relates to a process for producing the uncooked dry or semi-dry sausage product. | 2009-07-30 |
20090191316 | RETRACTABLE CANDY HOLDER - The present invention is a holder for a confectionary product. The holder has two sections that enclose the confectionary product when in the closed position. The holder may be opened by sliding the two sections apart and then pivoting one of the sections relative to the other one hundred and eighty degrees to intermesh and thereby form a handle for holding the confectionary product during consumption by a user. | 2009-07-30 |
20090191317 | DOUBLE-STACK SHRIMP TRAY - A tiered shrimp food tray including a sheet of material forming a base tray having an outer ridge, a support ridge formed concentric to and in spaced relation to the outer ridge. An inner ridge and a base surface cooperatively define a central well which supports a condiment cup. A ring of shrimp is arranged on the support ridge of the base tray. A connector plate interconnects the base tray with an upper tray. The upper tray includes an outer ridge and a support ridge spaced from one another. A second condiment cup is disposed within a well of the upper tray. A ring of shrimp is arranged on the support ridge of the upper tray. | 2009-07-30 |